| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 6.31e-06 | 8 | 98 | 3 | GO:0098882 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.29e-05 | 42 | 98 | 4 | GO:0098918 | |
| GeneOntologyBiologicalProcess | mRNA processing | SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 NCBP3 DDX46 ZFP36L1 RBM27 LUC7L2 PCIF1 RBM15B DDX23 ACIN1 RSRP1 SCAF11 SYMPK | 9.52e-12 | 551 | 97 | 19 | GO:0006397 |
| GeneOntologyBiologicalProcess | RNA splicing | CCNL2 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 DDX46 LUC7L2 RBM15B DDX23 ACIN1 RSRP1 SCAF11 TRPT1 | 1.55e-09 | 502 | 97 | 16 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | NCOA2 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 NCBP3 DDX46 ZFP36L1 RBM27 LUC7L2 PCIF1 RBM15B DDX23 ACIN1 RSRP1 SCAF11 SYMPK | 7.85e-09 | 917 | 97 | 20 | GO:0016071 |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 2.15e-08 | 99 | 97 | 8 | GO:0000245 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | SRSF3 SRSF4 SRSF5 BUD13 YTHDC1 DDX46 LUC7L2 RBM15B DDX23 ACIN1 RSRP1 SCAF11 | 1.18e-07 | 358 | 97 | 12 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | SRSF3 SRSF4 SRSF5 BUD13 YTHDC1 DDX46 LUC7L2 RBM15B DDX23 ACIN1 RSRP1 SCAF11 | 1.18e-07 | 358 | 97 | 12 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | SRSF3 SRSF4 SRSF5 BUD13 YTHDC1 DDX46 LUC7L2 RBM15B DDX23 ACIN1 RSRP1 SCAF11 | 1.33e-07 | 362 | 97 | 12 | GO:0000375 |
| GeneOntologyBiologicalProcess | RNA processing | CCNL2 GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 NCBP3 DDX46 ZFP36L1 RBM27 LUC7L2 PCIF1 RBM15B DDX23 ACIN1 RSRP1 SCAF11 TRPT1 SYMPK | 1.34e-06 | 1500 | 97 | 22 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 6.05e-06 | 207 | 97 | 8 | GO:0043484 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 1.37e-05 | 65 | 97 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 2.00e-05 | 244 | 97 | 8 | GO:0022618 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 2.66e-05 | 254 | 97 | 8 | GO:0071826 | |
| GeneOntologyBiologicalProcess | mRNA transport | 6.36e-05 | 145 | 97 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.02e-04 | 158 | 97 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.15e-04 | 101 | 97 | 5 | GO:0043954 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.79e-04 | 175 | 97 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.79e-04 | 175 | 97 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.96e-04 | 178 | 97 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle exocytosis | 2.08e-04 | 62 | 97 | 4 | GO:2000300 | |
| GeneOntologyBiologicalProcess | chromatin organization | MYCN YTHDC1 EMSY BAZ1A CTR9 GLYR1 TONSL MKI67 RBM15B DDX23 CHD6 RERE NIPBL | 2.86e-04 | 896 | 97 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 3.24e-04 | 6 | 97 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.60e-04 | 129 | 97 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 4.11e-04 | 74 | 97 | 4 | GO:0006406 | |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 4.53e-04 | 7 | 97 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 5.43e-04 | 34 | 97 | 3 | GO:0035335 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.64e-04 | 217 | 97 | 6 | GO:0006403 | |
| GeneOntologyCellularComponent | nuclear body | NCOA2 CCNL2 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 AHCTF1 YTHDC1 NPHP4 TP53INP2 REXO1 NCBP3 DDX46 RBM27 CTR9 LUC7L2 TONSL MKI67 RBM15B ACIN1 SCAF11 RERE TOP3A SYMPK NPAT | 4.59e-14 | 903 | 98 | 26 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | CCNL2 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 YTHDC1 NCBP3 DDX46 RBM27 CTR9 LUC7L2 RBM15B ACIN1 | 1.37e-08 | 431 | 98 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 5.50e-06 | 8 | 98 | 3 | GO:0048788 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 3.50e-05 | 14 | 98 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.65e-04 | 23 | 98 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | inhibitory synapse | 4.08e-04 | 31 | 98 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | ribbon synapse | 4.49e-04 | 32 | 98 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.34e-04 | 141 | 98 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 AKAP17A AHCTF1 BUD13 MCM4 PAGR1 DDX46 BAZ1A CTR9 LUC7L2 TONSL DDX23 ACIN1 RERE NIPBL SYMPK | 6.43e-04 | 1377 | 98 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 7.67e-04 | 9 | 98 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 1.08e-03 | 96 | 98 | 4 | GO:0097525 | |
| GeneOntologyCellularComponent | MCM complex | 1.16e-03 | 11 | 98 | 2 | GO:0042555 | |
| GeneOntologyCellularComponent | cell cortex region | 1.23e-03 | 45 | 98 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 1.62e-03 | 107 | 98 | 4 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 2.39e-03 | 119 | 98 | 4 | GO:0120114 | |
| Domain | - | 3.46e-05 | 244 | 95 | 8 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 5.13e-05 | 258 | 95 | 8 | IPR012677 | |
| Domain | Znf_FYVE-rel | 6.80e-04 | 34 | 95 | 3 | IPR017455 | |
| Domain | PDZ | 7.68e-04 | 141 | 95 | 5 | PF00595 | |
| Domain | RRM | 8.45e-04 | 217 | 95 | 6 | SM00360 | |
| Domain | Znf_FYVE_PHD | 9.26e-04 | 147 | 95 | 5 | IPR011011 | |
| Domain | Znf_FYVE | 9.45e-04 | 38 | 95 | 3 | IPR000306 | |
| Domain | PDZ | 9.54e-04 | 148 | 95 | 5 | SM00228 | |
| Domain | - | 1.01e-03 | 150 | 95 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.04e-03 | 151 | 95 | 5 | PS50106 | |
| Domain | RRM_dom | 1.07e-03 | 227 | 95 | 6 | IPR000504 | |
| Domain | PDZ | 1.08e-03 | 152 | 95 | 5 | IPR001478 | |
| Domain | ZF_FYVE | 1.10e-03 | 40 | 95 | 3 | PS50178 | |
| Domain | - | 1.10e-03 | 40 | 95 | 3 | 4.10.1000.10 | |
| Domain | RRM | 1.14e-03 | 230 | 95 | 6 | PS50102 | |
| Domain | FYVE_2 | 1.37e-03 | 11 | 95 | 2 | PF02318 | |
| Domain | RABBD | 1.63e-03 | 12 | 95 | 2 | PS50916 | |
| Domain | Rab_BD | 1.63e-03 | 12 | 95 | 2 | IPR010911 | |
| Domain | zf-CCCH | 1.98e-03 | 49 | 95 | 3 | PF00642 | |
| Domain | Znf_CCCH | 3.21e-03 | 58 | 95 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 3.21e-03 | 58 | 95 | 3 | PS50103 | |
| Domain | RRM_1 | 4.21e-03 | 208 | 95 | 5 | PF00076 | |
| Domain | Ank | 6.18e-03 | 228 | 95 | 5 | PF00023 | |
| Domain | FERM_C | 7.68e-03 | 26 | 95 | 2 | PF09380 | |
| Domain | Bromodomain_CS | 7.68e-03 | 26 | 95 | 2 | IPR018359 | |
| Domain | - | 7.97e-03 | 449 | 95 | 7 | 3.30.40.10 | |
| Domain | FERM_C | 8.27e-03 | 27 | 95 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 8.27e-03 | 27 | 95 | 2 | IPR018980 | |
| Domain | AT_hook | 8.27e-03 | 27 | 95 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.27e-03 | 27 | 95 | 2 | IPR017956 | |
| Domain | - | 8.72e-03 | 248 | 95 | 5 | 1.25.40.20 | |
| Domain | Znf_RING/FYVE/PHD | 8.94e-03 | 459 | 95 | 7 | IPR013083 | |
| Pathway | KEGG_SPLICEOSOME | 1.93e-05 | 127 | 62 | 6 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.16e-05 | 283 | 62 | 8 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.84e-05 | 212 | 62 | 7 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.05e-04 | 277 | 62 | 7 | MM15414 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.11e-04 | 67 | 62 | 4 | M27694 | |
| Pathway | REACTOME_MRNA_SPLICING | 2.47e-04 | 201 | 62 | 6 | MM15411 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN SRSF5 ZC3H13 GTSE1 BUD13 MCM4 PAGR1 YTHDC1 REXO1 EMSY FBXO38 DDX46 BRAF CTR9 MKI67 RBM15B ACIN1 SCAF11 RIMS1 RERE NIPBL SYMPK | 4.71e-16 | 774 | 100 | 22 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 PAGR1 YTHDC1 EMSY DDX46 RBM27 BAZ1A CTR9 LUC7L2 GLYR1 TONSL MKI67 RBM15B DDX23 ACIN1 SCAF11 CHD6 NKTR NIPBL TOP3A SYMPK | 2.67e-15 | 1294 | 100 | 26 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRSF3 SRSF4 ZC3H13 AHCTF1 GTSE1 BUD13 MCM4 EMSY NCBP3 DDX46 RBM27 BAZ1A TJP1 PRRC2C MKI67 RBM15B ACIN1 SCAF11 NIPBL SYMPK NPAT | 3.39e-13 | 954 | 100 | 21 | 36373674 |
| Pubmed | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 MCM4 DDX46 TJP1 PRRC2C GLYR1 MKI67 DDX23 ACIN1 SCAF11 NIPBL SYMPK | 5.71e-12 | 653 | 100 | 17 | 22586326 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | GTPBP4 SRSF3 SRSF5 ZC3H13 NCBP3 DDX46 BAZ1A CTR9 PRRC2C LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 SCAF11 | 2.02e-11 | 605 | 100 | 16 | 28977666 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 PTPN13 DDX46 RBM27 TJP1 LUC7L2 GLYR1 RBM15B DDX23 ACIN1 CHD6 NIPBL SYMPK | 3.08e-11 | 1082 | 100 | 20 | 38697112 |
| Pubmed | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 YTHDC1 DDX46 RBM27 BAZ1A TJP1 LUC7L2 GLYR1 MKI67 RBM15B ACIN1 SCAF11 SYMPK | 3.59e-11 | 847 | 100 | 18 | 35850772 | |
| Pubmed | DTD1 GTPBP4 SRSF5 AKAP17A AHCTF1 PEG3 NCBP3 DDX46 BRAF RBM27 BAZ1A TJP1 PRRC2C LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 SCAF11 NKTR TRPT1 | 4.18e-11 | 1371 | 100 | 22 | 36244648 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.54e-10 | 130 | 100 | 9 | 35545047 | |
| Pubmed | SRSF4 AKAP17A ZC3H13 BUD13 CTR9 PRRC2C RBM15B DDX23 ACIN1 SCAF11 SYMPK | 1.79e-10 | 251 | 100 | 11 | 31076518 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GTPBP4 SRSF3 SRSF4 AKAP17A ZC3H13 AHCTF1 MCM4 YTHDC1 EMSY GPALPP1 DDX46 RBM27 CTR9 LUC7L2 MKI67 DDX23 ACIN1 CHD6 NKTR NIPBL | 9.68e-10 | 1318 | 100 | 20 | 30463901 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 YTHDC1 NCBP3 DDX46 RBM27 PRRC2C LUC7L2 RBM15B DDX23 ACIN1 SCAF11 | 1.34e-09 | 807 | 100 | 16 | 22681889 |
| Pubmed | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 YTHDC1 NCBP3 RBM27 PRRC2C MKI67 RBM15B DDX23 ACIN1 NKTR SYMPK | 2.08e-09 | 713 | 100 | 15 | 29802200 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 AHCTF1 EMSY NCBP3 FBXO38 RNF220 BAZ1A GLYR1 MKI67 SCAF11 CHD6 NIPBL BRWD1 NPAT | 2.39e-09 | 608 | 100 | 14 | 36089195 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | GTPBP4 SRSF4 SRSF5 AHCTF1 BUD13 YTHDC1 LUC7L2 ACIN1 NKTR NIPBL | 4.24e-09 | 259 | 100 | 10 | 30404004 |
| Pubmed | NCOA2 KIF21B GTPBP4 GPRASP1 SGIP1 GIT2 EMSY SHANK2 FAM171A2 TJP1 PRRC2C KCNMA1 RIMS1 BSN NIPBL AGAP2 | 1.62e-08 | 963 | 100 | 16 | 28671696 | |
| Pubmed | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 BUD13 DDX46 RBM27 CTR9 PRRC2C LUC7L2 RBM15B DDX23 ACIN1 | 2.42e-08 | 731 | 100 | 14 | 29298432 | |
| Pubmed | ZC3H13 AHCTF1 GTSE1 MCM4 YTHDC1 BRAF RBM27 CTR9 MKI67 FAM83G ACIN1 NIPBL | 2.44e-08 | 503 | 100 | 12 | 16964243 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GTPBP4 SRSF5 AKAP17A BUD13 NCBP3 DDX46 RBM27 BAZ1A PRRC2C GLYR1 MKI67 RBM15B ACIN1 SCAF11 | 3.86e-08 | 759 | 100 | 14 | 35915203 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 SRSF3 AHCTF1 MCM4 EMSY GPALPP1 PTPN13 DDX46 RBM27 BAZ1A TJP1 PRRC2C MKI67 ACIN1 NIPBL | 7.38e-08 | 934 | 100 | 15 | 33916271 |
| Pubmed | NCOA2 ZNF821 KLF12 ZC3H13 AHCTF1 PEG3 ANKRD6 RPS6KC1 PTPN13 BRAF BAZ1A CTR9 GLYR1 ACIN1 BRWD1 NPAT | 8.22e-08 | 1084 | 100 | 16 | 11544199 | |
| Pubmed | 9.34e-08 | 128 | 100 | 7 | 30995482 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 GTSE1 NPHP4 EMSY MKI67 ACIN1 | 9.70e-08 | 361 | 100 | 10 | 30344098 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GTPBP4 SRSF3 SRSF5 ZC3H13 BUD13 YTHDC1 DDX46 BAZ1A PRRC2C RBM15B | 9.70e-08 | 361 | 100 | 10 | 26167880 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | LPCAT1 SRSF3 SRSF4 SRSF5 EPB41L4A YTHDC1 NCBP3 DDX46 SHANK2 LUC7L2 DDX23 ACIN1 RSRP1 | 1.05e-07 | 695 | 100 | 13 | 23602568 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.37e-07 | 283 | 100 | 9 | 30585729 | |
| Pubmed | 1.38e-07 | 203 | 100 | 8 | 35012549 | ||
| Pubmed | KIF21B GTPBP4 SRSF4 SRSF5 NCBP3 DDX46 BAZ1A TJP1 CTR9 MKI67 DDX23 ACIN1 | 4.53e-07 | 660 | 100 | 12 | 32780723 | |
| Pubmed | SR proteins: a conserved family of pre-mRNA splicing factors. | 4.58e-07 | 6 | 100 | 3 | 1577277 | |
| Pubmed | 5.59e-07 | 244 | 100 | 8 | 29884807 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.55e-07 | 341 | 100 | 9 | 32971831 | |
| Pubmed | 7.57e-07 | 347 | 100 | 9 | 16033648 | ||
| Pubmed | NCOA2 GPRASP1 ZNF821 AKAP17A PEG3 WHAMM ANKRD6 DIP2A RNF220 PTPN13 TJP1 CTR9 CHD6 NIPBL AGAP2 BRWD1 | 7.97e-07 | 1285 | 100 | 16 | 35914814 | |
| Pubmed | A serine kinase regulates intracellular localization of splicing factors in the cell cycle. | 8.01e-07 | 7 | 100 | 3 | 8208298 | |
| Pubmed | Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing. | 8.01e-07 | 7 | 100 | 3 | 9447963 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 8.50e-07 | 258 | 100 | 8 | 37794589 | |
| Pubmed | 1.06e-06 | 115 | 100 | 6 | 17332742 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.09e-06 | 184 | 100 | 7 | 32908313 | |
| Pubmed | SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1. | 1.28e-06 | 8 | 100 | 3 | 10390541 | |
| Pubmed | 1.45e-06 | 29 | 100 | 4 | 17577209 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.72e-06 | 197 | 100 | 7 | 22365833 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 14623875 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 19857271 | ||
| Pubmed | 2.73e-06 | 10 | 100 | 3 | 16543498 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.98e-06 | 410 | 100 | 9 | 26949251 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DTD1 GTPBP4 SRSF3 ZC3H13 AHCTF1 BUD13 YTHDC1 RBM27 TJP1 PRRC2C GLYR1 MKI67 RBM15B ACIN1 SCAF11 | 3.08e-06 | 1257 | 100 | 15 | 36526897 |
| Pubmed | 3.15e-06 | 35 | 100 | 4 | 33864728 | ||
| Pubmed | NCOA2 AHCTF1 EMSY PTPN13 DDX46 RBM27 TJP1 PRRC2C ACIN1 SYMPK | 4.30e-06 | 549 | 100 | 10 | 38280479 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.93e-06 | 231 | 100 | 7 | 16452087 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | GTPBP4 SRSF3 MCM4 YTHDC1 RBM27 CTR9 LUC7L2 GLYR1 MKI67 DDX23 ACIN1 SCAF11 SYMPK | 5.32e-06 | 989 | 100 | 13 | 36424410 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.50e-06 | 332 | 100 | 8 | 32786267 | |
| Pubmed | 5.50e-06 | 332 | 100 | 8 | 25693804 | ||
| Pubmed | AKAP17A AHCTF1 WHAMM BUD13 YTHDC1 EMSY PTPN13 DDX46 SHANK2 RBM27 BAZ1A CTR9 RBM15B SCAF11 CHD6 NIPBL | 5.67e-06 | 1497 | 100 | 16 | 31527615 | |
| Pubmed | 5.88e-06 | 335 | 100 | 8 | 15741177 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 6.43e-06 | 90 | 100 | 5 | 35654790 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 6.46e-06 | 13 | 100 | 3 | 20516191 | |
| Pubmed | GTPBP4 MCM4 RABGAP1 YTHDC1 DDX46 RBM27 BAZ1A CTR9 MKI67 DDX23 ACIN1 NIPBL SYMPK | 6.96e-06 | 1014 | 100 | 13 | 32416067 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | GTPBP4 SRSF3 SRSF4 SRSF5 DDX46 LUC7L2 DDX23 ACIN1 NIPBL SYMPK | 7.16e-06 | 582 | 100 | 10 | 20467437 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 7.83e-06 | 588 | 100 | 10 | 38580884 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19199833 | ||
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 8.18e-06 | 2 | 100 | 2 | 25240052 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15226444 | ||
| Pubmed | Multiple Phosphorylations of SR Protein SRSF3 and Its Binding to m6A Reader YTHDC1 in Human Cells. | 8.18e-06 | 2 | 100 | 2 | 35563766 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17972530 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29857020 | ||
| Pubmed | Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses. | 8.18e-06 | 2 | 100 | 2 | 28701482 | |
| Pubmed | RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes. | 8.18e-06 | 2 | 100 | 2 | 29606581 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22436691 | ||
| Pubmed | Global analysis reveals SRp20- and SRp75-specific mRNPs in cycling and neural cells. | 8.18e-06 | 2 | 100 | 2 | 20639886 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26400943 | ||
| Pubmed | A presynaptic phosphosignaling hub for lasting homeostatic plasticity. | 8.18e-06 | 2 | 100 | 2 | 35443170 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35660571 | ||
| Pubmed | RIM genes differentially contribute to organizing presynaptic release sites. | 8.18e-06 | 2 | 100 | 2 | 22753485 | |
| Pubmed | Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. | 8.18e-06 | 2 | 100 | 2 | 22492957 | |
| Pubmed | The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus. | 8.18e-06 | 2 | 100 | 2 | 22956829 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33774706 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 16452088 | ||
| Pubmed | 8.78e-06 | 469 | 100 | 9 | 27634302 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 8.83e-06 | 96 | 100 | 5 | 25948554 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 9.84e-06 | 169 | 100 | 6 | 23084401 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.21e-05 | 370 | 100 | 8 | 22922362 | |
| Pubmed | 1.30e-05 | 268 | 100 | 7 | 33640491 | ||
| Pubmed | 1.30e-05 | 104 | 100 | 5 | 31365120 | ||
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 1.30e-05 | 104 | 100 | 5 | 26167872 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | NCOA2 TANK SRSF3 SRSF4 SRSF5 ZC3H13 YTHDC1 PTPN13 DUSP16 ACIN1 RSRP1 SYMPK | 1.39e-05 | 922 | 100 | 12 | 27609421 |
| Pubmed | NCOA2 GTPBP4 KLF12 PAGR1 EMSY RBM27 PRRC2C GLYR1 MKI67 SCAF11 CHD6 RERE NIPBL SYMPK NPAT | 1.42e-05 | 1429 | 100 | 15 | 35140242 | |
| Pubmed | RPS6KC1 GPALPP1 SHANK2 BAZ1A TJP1 CTR9 PRRC2C DDX23 ACIN1 CHD6 RIMS1 BSN RIMS2 NIPBL AGAP2 | 1.58e-05 | 1442 | 100 | 15 | 35575683 | |
| Pubmed | 1.80e-05 | 188 | 100 | 6 | 29721183 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.90e-05 | 394 | 100 | 8 | 27248496 | |
| Pubmed | 1.93e-05 | 653 | 100 | 10 | 33742100 | ||
| Pubmed | GTPBP4 SRSF3 DDX46 PRRC2C LUC7L2 MKI67 DDX23 ACIN1 CHD6 RERE | 1.98e-05 | 655 | 100 | 10 | 35819319 | |
| Pubmed | NCOA2 MYCN KLF12 ZC3H13 AHCTF1 PEG3 ZFP36L1 BAZ1A GLYR1 ACIN1 MESP2 | 2.15e-05 | 808 | 100 | 11 | 20412781 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | LPCAT1 SRSF4 SRSF5 GTSE1 MCM4 LUC7L2 MKI67 DDX23 SCAF11 GPANK1 | 2.40e-05 | 670 | 100 | 10 | 22990118 |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 38745192 | ||
| Pubmed | RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone. | 2.45e-05 | 3 | 100 | 2 | 21262468 | |
| Pubmed | YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. | 2.45e-05 | 3 | 100 | 2 | 28984244 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26034270 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 28377503 | ||
| Pubmed | RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. | 2.45e-05 | 3 | 100 | 2 | 21241895 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25343783 | ||
| Interaction | SRPK2 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 MCM4 EPB41L4A YTHDC1 NCBP3 DDX46 RBM27 BAZ1A PRRC2C LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 RSRP1 SCAF11 NKTR | 6.05e-15 | 717 | 99 | 25 | int:SRPK2 |
| Interaction | NUP43 interactions | SRSF3 ZC3H13 AHCTF1 BUD13 YTHDC1 EMSY NCBP3 GPALPP1 RNF220 BAZ1A PRRC2C LUC7L2 GLYR1 TONSL MKI67 ACIN1 CHD6 NKTR RERE NIPBL NPAT | 2.53e-12 | 625 | 99 | 21 | int:NUP43 |
| Interaction | SRPK1 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 MCM4 EPB41L4A YTHDC1 NEK4 DDX46 RBM27 LUC7L2 MKI67 DDX23 ACIN1 RSRP1 SCAF11 | 1.60e-10 | 477 | 99 | 17 | int:SRPK1 |
| Interaction | YWHAG interactions | MYCN KIF21B GTPBP4 SRSF3 AKAP17A ZC3H13 GTSE1 TNS2 GIT2 NEK4 PTPN13 BRAF FAM171A2 ZFP36L1 BAZ1A TJP1 PRRC2C LUC7L2 DUSP16 KCNMA1 RBM15B FAM83G ACIN1 SCAF11 NKTR FAM110B | 1.95e-10 | 1248 | 99 | 26 | int:YWHAG |
| Interaction | SRSF4 interactions | MYCN SRSF3 SRSF4 SRSF5 AKAP17A BUD13 YTHDC1 NCBP3 GLYR1 MKI67 DDX23 ACIN1 SCAF11 NKTR | 2.37e-10 | 300 | 99 | 14 | int:SRSF4 |
| Interaction | SRSF6 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 NCBP3 LUC7L2 GLYR1 MKI67 DDX23 ACIN1 SCAF11 NKTR | 3.62e-10 | 503 | 99 | 17 | int:SRSF6 |
| Interaction | DHX8 interactions | SRSF4 AKAP17A ZC3H13 BUD13 GPALPP1 DDX46 RBM27 CTR9 LUC7L2 DDX23 SCAF11 NKTR SYMPK | 1.93e-09 | 292 | 99 | 13 | int:DHX8 |
| Interaction | MECP2 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 PTPN13 DDX46 RBM27 BAZ1A TJP1 LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 CHD6 NKTR NIPBL TOP3A SYMPK | 2.00e-09 | 1287 | 99 | 25 | int:MECP2 |
| Interaction | DDX23 interactions | MYCN GTPBP4 SRSF4 AKAP17A ZC3H13 BUD13 MCM4 YTHDC1 GPALPP1 DDX46 CTR9 DDX23 ACIN1 SCAF11 NKTR | 1.25e-08 | 480 | 99 | 15 | int:DDX23 |
| Interaction | SNRNP40 interactions | MYCN SRSF3 AKAP17A ZC3H13 AHCTF1 BUD13 MCM4 YTHDC1 EMSY GPALPP1 TONSL MKI67 DDX23 ACIN1 SCAF11 NKTR NPAT | 1.26e-08 | 637 | 99 | 17 | int:SNRNP40 |
| Interaction | SMC5 interactions | SRSF3 SRSF4 ZC3H13 AHCTF1 GTSE1 BUD13 MCM4 EMSY NCBP3 DDX46 RBM27 BAZ1A TJP1 PRRC2C MKI67 RBM15B ACIN1 SCAF11 NIPBL SYMPK NPAT | 1.33e-08 | 1000 | 99 | 21 | int:SMC5 |
| Interaction | SNIP1 interactions | MYCN GTPBP4 SRSF4 SRSF5 AHCTF1 BUD13 YTHDC1 NCBP3 GPALPP1 LUC7L2 RBM15B ACIN1 NKTR NIPBL | 1.63e-08 | 417 | 99 | 14 | int:SNIP1 |
| Interaction | EZH1 interactions | 1.69e-08 | 92 | 99 | 8 | int:EZH1 | |
| Interaction | RNPS1 interactions | CCNL2 MYCN SRSF3 SRSF4 AKAP17A YTHDC1 NCBP3 GPALPP1 DDX46 LUC7L2 MKI67 DDX23 ACIN1 NKTR | 2.07e-08 | 425 | 99 | 14 | int:RNPS1 |
| Interaction | LINC02910 interactions | 2.18e-08 | 95 | 99 | 8 | int:LINC02910 | |
| Interaction | CHD3 interactions | GTPBP4 KLF12 SRSF3 SRSF5 ZC3H13 NCBP3 DDX46 BAZ1A CTR9 PRRC2C LUC7L2 GLYR1 MKI67 DDX23 ACIN1 SCAF11 CHD6 SYMPK | 2.63e-08 | 757 | 99 | 18 | int:CHD3 |
| Interaction | PNN interactions | MYCN SRSF3 SRSF4 AKAP17A YTHDC1 NCBP3 GPALPP1 LUC7L2 MKI67 DDX23 ACIN1 NKTR | 2.98e-08 | 302 | 99 | 12 | int:PNN |
| Interaction | CPSF6 interactions | MYCN AKAP17A BUD13 YTHDC1 NCBP3 NEK4 TJP1 CTR9 LUC7L2 DDX23 ACIN1 RSRP1 SCAF11 NKTR SYMPK | 4.18e-08 | 526 | 99 | 15 | int:CPSF6 |
| Interaction | SRSF11 interactions | 6.16e-08 | 203 | 99 | 10 | int:SRSF11 | |
| Interaction | DOT1L interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 YTHDC1 DDX46 RBM27 BAZ1A LUC7L2 GLYR1 MKI67 RBM15B ACIN1 SCAF11 SYMPK | 6.91e-08 | 807 | 99 | 18 | int:DOT1L |
| Interaction | SUZ12 interactions | MYCN GTPBP4 SRSF3 SRSF5 ZC3H13 AHCTF1 MCM4 YTHDC1 NCBP3 LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 SCAF11 | 9.47e-08 | 644 | 99 | 16 | int:SUZ12 |
| Interaction | ZC3H11A interactions | MYCN SRSF3 AKAP17A YTHDC1 NPHP4 NCBP3 RBM27 MKI67 ACIN1 NKTR | 1.06e-07 | 215 | 99 | 10 | int:ZC3H11A |
| Interaction | SIRT7 interactions | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 MCM4 DDX46 TJP1 PRRC2C GLYR1 MKI67 DDX23 ACIN1 SCAF11 NIPBL SYMPK | 1.19e-07 | 744 | 99 | 17 | int:SIRT7 |
| Interaction | ZC3H18 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A ZC3H13 BUD13 YTHDC1 DDX46 RBM27 CTR9 PRRC2C LUC7L2 RBM15B DDX23 ACIN1 NKTR | 2.38e-07 | 877 | 99 | 18 | int:ZC3H18 |
| Interaction | SCAF11 interactions | 2.84e-07 | 132 | 99 | 8 | int:SCAF11 | |
| Interaction | YWHAH interactions | NCOA2 KIF21B ZC3H13 GTSE1 TNS2 GIT2 PTPN13 BRAF FAM171A2 ZFP36L1 TJP1 PRRC2C DUSP16 KCNMA1 RBM15B FAM83G NKTR RIMS1 RIMS2 FAM110B | 3.33e-07 | 1102 | 99 | 20 | int:YWHAH |
| Interaction | GNL2 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 DDX46 RBM27 TJP1 MKI67 RBM15B DDX23 | 4.24e-07 | 386 | 99 | 12 | int:GNL2 |
| Interaction | CLK2 interactions | 5.05e-07 | 195 | 99 | 9 | int:CLK2 | |
| Interaction | MEN1 interactions | GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 AHCTF1 YTHDC1 EMSY NCBP3 DDX46 BAZ1A TJP1 GLYR1 MKI67 DDX23 ACIN1 SCAF11 RERE SYMPK | 5.31e-07 | 1029 | 99 | 19 | int:MEN1 |
| Interaction | H3C3 interactions | GTPBP4 AHCTF1 NCBP3 FBXO38 RNF220 BAZ1A GLYR1 TONSL MKI67 SCAF11 CHD6 NIPBL NPAT | 9.14e-07 | 495 | 99 | 13 | int:H3C3 |
| Interaction | NCBP3 interactions | 1.02e-06 | 156 | 99 | 8 | int:NCBP3 | |
| Interaction | SRSF7 interactions | MYCN SRSF3 SRSF4 SRSF5 YTHDC1 NCBP3 DDX46 LUC7L2 GLYR1 DDX23 ACIN1 NKTR | 1.17e-06 | 425 | 99 | 12 | int:SRSF7 |
| Interaction | SNRNP70 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 YTHDC1 NCBP3 RBM27 PRRC2C LUC7L2 MKI67 RBM15B DDX23 ACIN1 SCAF11 NKTR SYMPK | 1.27e-06 | 984 | 99 | 18 | int:SNRNP70 |
| Interaction | PPIE interactions | 1.28e-06 | 282 | 99 | 10 | int:PPIE | |
| Interaction | RAD18 interactions | SRSF4 AKAP17A ZC3H13 BUD13 TJP1 CTR9 PRRC2C RBM15B DDX23 ACIN1 SCAF11 SYMPK | 2.49e-06 | 457 | 99 | 12 | int:RAD18 |
| Interaction | PSENEN interactions | 2.91e-06 | 81 | 99 | 6 | int:PSENEN | |
| Interaction | CHD4 interactions | MYCN GTPBP4 SRSF3 SRSF5 MCM4 NPHP4 NCBP3 DDX46 CTR9 PRRC2C LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 SCAF11 | 2.95e-06 | 938 | 99 | 17 | int:CHD4 |
| Interaction | NR2C2 interactions | GTPBP4 KLF12 SRSF3 SRSF4 AKAP17A ZC3H13 AHCTF1 MCM4 YTHDC1 EMSY GPALPP1 DDX46 RBM27 CTR9 LUC7L2 MKI67 DDX23 ACIN1 CHD6 NKTR NIPBL | 3.63e-06 | 1403 | 99 | 21 | int:NR2C2 |
| Interaction | SRSF1 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A YTHDC1 NEK4 DDX46 PRRC2C LUC7L2 GLYR1 SCAF11 | 4.32e-06 | 570 | 99 | 13 | int:SRSF1 |
| Interaction | SRPK3 interactions | 4.43e-06 | 190 | 99 | 8 | int:SRPK3 | |
| Interaction | ADARB1 interactions | MYCN GTPBP4 SRSF5 AHCTF1 BUD13 MCM4 YTHDC1 DDX46 GLYR1 MKI67 ACIN1 NKTR | 4.97e-06 | 489 | 99 | 12 | int:ADARB1 |
| Interaction | PRP4K interactions | 5.05e-06 | 329 | 99 | 10 | int:PRP4K | |
| Interaction | JMJD6 interactions | 7.75e-06 | 205 | 99 | 8 | int:JMJD6 | |
| Interaction | SF3A2 interactions | 8.05e-06 | 273 | 99 | 9 | int:SF3A2 | |
| Interaction | FMR1 interactions | NCOA2 MYCN KIF21B EMSY FAM171A2 TJP1 PRRC2C MKI67 KCNMA1 BSN NIPBL AGAP2 | 1.25e-05 | 536 | 99 | 12 | int:FMR1 |
| Interaction | CLK1 interactions | 1.25e-05 | 219 | 99 | 8 | int:CLK1 | |
| Interaction | CLK3 interactions | 1.30e-05 | 220 | 99 | 8 | int:CLK3 | |
| Interaction | TUBGCP6 interactions | 1.45e-05 | 63 | 99 | 5 | int:TUBGCP6 | |
| Interaction | NKAPD1 interactions | 1.47e-05 | 161 | 99 | 7 | int:NKAPD1 | |
| Interaction | NLE1 interactions | 1.68e-05 | 228 | 99 | 8 | int:NLE1 | |
| Interaction | H3-3A interactions | MYCN AHCTF1 EMSY NCBP3 FBXO38 RNF220 BAZ1A GLYR1 MKI67 DDX23 SCAF11 NIPBL BRWD1 NPAT | 1.73e-05 | 749 | 99 | 14 | int:H3-3A |
| Interaction | U2AF2 interactions | MYCN SRSF3 SRSF4 SRSF5 ZC3H13 DDX46 TJP1 LUC7L2 MKI67 DDX23 ACIN1 SCAF11 NKTR | 1.79e-05 | 651 | 99 | 13 | int:U2AF2 |
| Interaction | BECN2 interactions | 1.84e-05 | 11 | 99 | 3 | int:BECN2 | |
| Interaction | CDKL5 interactions | 1.99e-05 | 113 | 99 | 6 | int:CDKL5 | |
| Interaction | ZC3H14 interactions | 2.01e-05 | 169 | 99 | 7 | int:ZC3H14 | |
| Interaction | CIT interactions | GTPBP4 GPRASP1 SRSF3 SRSF5 ZC3H13 AHCTF1 MCM4 DDX46 RBM27 TJP1 CTR9 PRRC2C GLYR1 MKI67 DDX23 ACIN1 SCAF11 NKTR NIPBL SYMPK | 2.14e-05 | 1450 | 99 | 20 | int:CIT |
| Interaction | SNRPA interactions | MYCN SRSF4 YTHDC1 NCBP3 CTR9 PRRC2C DDX23 ACIN1 SCAF11 NKTR SYMPK | 2.48e-05 | 482 | 99 | 11 | int:SNRPA |
| Interaction | SSRP1 interactions | MYCN ZC3H13 MCM4 YTHDC1 REXO1 CTR9 TONSL DDX23 ACIN1 SCAF11 NIPBL SYMPK BRWD1 | 3.04e-05 | 685 | 99 | 13 | int:SSRP1 |
| Interaction | DHX40 interactions | 3.16e-05 | 249 | 99 | 8 | int:DHX40 | |
| Interaction | TOP1 interactions | MYCN BUD13 MCM4 YTHDC1 NEK4 BAZ1A CTR9 MKI67 DDX23 ACIN1 SCAF11 NIPBL SYMPK | 3.58e-05 | 696 | 99 | 13 | int:TOP1 |
| Interaction | H2AJ interactions | 3.86e-05 | 127 | 99 | 6 | int:H2AJ | |
| Interaction | ANAPC15 interactions | 4.03e-05 | 128 | 99 | 6 | int:ANAPC15 | |
| Interaction | CDX1 interactions | 4.64e-05 | 80 | 99 | 5 | int:CDX1 | |
| Interaction | CLUH interactions | 4.65e-05 | 263 | 99 | 8 | int:CLUH | |
| Interaction | IFI16 interactions | GTPBP4 SRSF4 SRSF5 AHCTF1 BUD13 MCM4 YTHDC1 NCBP3 TJP1 GLYR1 MKI67 DDX23 ACIN1 | 4.65e-05 | 714 | 99 | 13 | int:IFI16 |
| Interaction | SNRPB interactions | MYCN SRSF4 YTHDC1 NCBP3 DDX46 CTR9 DDX23 ACIN1 SCAF11 NKTR SYMPK | 4.69e-05 | 517 | 99 | 11 | int:SNRPB |
| Interaction | NKAP interactions | 4.79e-05 | 132 | 99 | 6 | int:NKAP | |
| Interaction | CSNK2A2 interactions | CCNL2 MYCN GTPBP4 TANK AKAP17A GIT2 EMSY CTR9 PRRC2C LUC7L2 MKI67 NKTR AGAP2 | 4.93e-05 | 718 | 99 | 13 | int:CSNK2A2 |
| Interaction | RRS1 interactions | 5.09e-05 | 345 | 99 | 9 | int:RRS1 | |
| Interaction | RPL26L1 interactions | MYCN GTPBP4 KLF12 SRSF3 SRSF4 SRSF5 AKAP17A BUD13 MKI67 PLEKHO1 | 5.15e-05 | 431 | 99 | 10 | int:RPL26L1 |
| Interaction | ZCRB1 interactions | 5.22e-05 | 134 | 99 | 6 | int:ZCRB1 | |
| Interaction | SCAF1 interactions | 5.66e-05 | 136 | 99 | 6 | int:SCAF1 | |
| Interaction | HSPA2 interactions | 6.12e-05 | 440 | 99 | 10 | int:HSPA2 | |
| Interaction | SNRPC interactions | 6.12e-05 | 440 | 99 | 10 | int:SNRPC | |
| Interaction | CCDC9 interactions | 7.33e-05 | 88 | 99 | 5 | int:CCDC9 | |
| Interaction | SNW1 interactions | NCOA2 MYCN GTPBP4 SRSF3 SRSF5 RABGAP1 DDX46 LUC7L2 MKI67 DDX23 ACIN1 NIPBL SYMPK | 7.36e-05 | 747 | 99 | 13 | int:SNW1 |
| Interaction | SON interactions | 7.52e-05 | 208 | 99 | 7 | int:SON | |
| Interaction | THOC1 interactions | 7.99e-05 | 210 | 99 | 7 | int:THOC1 | |
| Interaction | NAA40 interactions | GTPBP4 SRSF3 AHCTF1 MCM4 EMSY GPALPP1 PTPN13 DDX46 RBM27 BAZ1A TJP1 PRRC2C MKI67 ACIN1 NIPBL | 8.26e-05 | 978 | 99 | 15 | int:NAA40 |
| Interaction | TERF2IP interactions | NCOA2 AHCTF1 EMSY RBM27 TJP1 MKI67 DDX23 SCAF11 NIPBL SYMPK NPAT | 8.42e-05 | 552 | 99 | 11 | int:TERF2IP |
| Interaction | GSK3B interactions | LPCAT1 TANK ANKRD6 RNF220 PTPN13 TJP1 PRRC2C LUC7L2 TONSL MKI67 DDX23 CHD6 PLEKHO1 AGAP2 | 8.60e-05 | 868 | 99 | 14 | int:GSK3B |
| Interaction | ATG2B interactions | 8.60e-05 | 91 | 99 | 5 | int:ATG2B | |
| Interaction | HECTD1 interactions | GTPBP4 SRSF5 AKAP17A BUD13 NCBP3 NEK4 DDX46 RBM27 BAZ1A PRRC2C GLYR1 MKI67 RBM15B ACIN1 SCAF11 | 8.85e-05 | 984 | 99 | 15 | int:HECTD1 |
| Interaction | SRRM2 interactions | MYCN SRSF3 SRSF4 SRSF5 AKAP17A NEK4 PRRC2C LUC7L2 DDX23 ACIN1 | 9.17e-05 | 462 | 99 | 10 | int:SRRM2 |
| Interaction | SRSF2 interactions | 9.21e-05 | 290 | 99 | 8 | int:SRSF2 | |
| Interaction | BMI1 interactions | MYCN SRSF3 SRSF4 ZC3H13 YTHDC1 NCBP3 BAZ1A PRRC2C MKI67 DDX23 ACIN1 SCAF11 | 9.30e-05 | 659 | 99 | 12 | int:BMI1 |
| Interaction | CENPA interactions | 1.00e-04 | 377 | 99 | 9 | int:CENPA | |
| Interaction | CPSF4 interactions | 1.00e-04 | 94 | 99 | 5 | int:CPSF4 | |
| Interaction | CDK13 interactions | 1.09e-04 | 153 | 99 | 6 | int:CDK13 | |
| Interaction | SRSF5 interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 AKAP17A BUD13 GLYR1 MKI67 SCAF11 | 1.13e-04 | 474 | 99 | 10 | int:SRSF5 |
| Interaction | MYCN interactions | MYCN GTPBP4 SRSF3 SRSF4 SRSF5 ZC3H13 BUD13 YTHDC1 NCBP3 DDX46 PRRC2C LUC7L2 GLYR1 MKI67 RBM15B DDX23 ACIN1 SCAF11 | 1.13e-04 | 1373 | 99 | 18 | int:MYCN |
| Interaction | SRSF8 interactions | 1.22e-04 | 98 | 99 | 5 | int:SRSF8 | |
| Interaction | YWHAE interactions | MYCN KIF21B SRSF4 GTSE1 TNS2 GIT2 NEK4 PTPN13 BRAF ZFP36L1 STK33 DUSP16 KCNMA1 FAM83G SCAF11 RIMS2 FAM110B | 1.23e-04 | 1256 | 99 | 17 | int:YWHAE |
| Interaction | YWHAB interactions | MYCN KIF21B SRSF3 TNS2 NEK4 PTPN13 BRAF FAM171A2 ZFP36L1 TJP1 CTR9 DUSP16 KCNMA1 FAM83G AGAP2 | 1.23e-04 | 1014 | 99 | 15 | int:YWHAB |
| Interaction | AKAP17A interactions | 1.28e-04 | 99 | 99 | 5 | int:AKAP17A | |
| Interaction | NUPR1 interactions | KIF21B GTPBP4 SRSF4 SRSF5 NCBP3 DDX46 BAZ1A TJP1 CTR9 MKI67 DDX23 ACIN1 | 1.30e-04 | 683 | 99 | 12 | int:NUPR1 |
| Interaction | SAP18 interactions | 1.30e-04 | 305 | 99 | 8 | int:SAP18 | |
| Interaction | HINFP interactions | 1.33e-04 | 53 | 99 | 4 | int:HINFP | |
| Interaction | UQCR11 interactions | 1.33e-04 | 53 | 99 | 4 | int:UQCR11 | |
| Interaction | PER1 interactions | 1.34e-04 | 100 | 99 | 5 | int:PER1 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 9.10e-06 | 12 | 64 | 3 | 737 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 7.37e-05 | 4 | 64 | 2 | 833 | |
| GeneFamily | PDZ domain containing | 2.01e-04 | 152 | 64 | 5 | 1220 | |
| GeneFamily | Ankyrin repeat domain containing | 2.12e-04 | 242 | 64 | 6 | 403 | |
| GeneFamily | RNA binding motif containing | 9.39e-04 | 213 | 64 | 5 | 725 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KIF21B KLF12 TANK SRSF3 AKAP17A GTSE1 MCM4 GIT2 YTHDC1 NPHP4 CEP68 DDX46 BAZ1A CTR9 PRRC2C TLL1 MKI67 KCNMA1 RSRP1 SCAF11 NKTR RIMS1 NPAT | 1.98e-09 | 1394 | 100 | 23 | M9585 |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.15e-05 | 199 | 100 | 7 | M7607 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.19e-05 | 200 | 100 | 7 | M9889 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DTD1 MYCN TANK SRSF5 ZC3H13 PEG3 GIT2 RPS6KC1 ZFP36L1 CTR9 KCNMA1 CHD6 RERE FAM110B | 2.91e-05 | 1009 | 100 | 14 | M157 |
| Coexpression | BENPORATH_CYCLING_GENES | SRSF3 SRSF5 GTSE1 MCM4 CTR9 MKI67 NKTR RERE NIPBL TOP3A NPAT | 3.74e-05 | 648 | 100 | 11 | M8156 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | AHCTF1 RPS6KC1 GPALPP1 PTPN13 DDX46 RBM27 BAZ1A MKI67 SCAF11 NKTR NIPBL | 4.18e-05 | 656 | 100 | 11 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B KLF12 TANK SRSF5 GIT2 YTHDC1 F2R PIKFYVE DIP2A ZFP36L1 RBM27 BAZ1A SCAF11 PLEKHO1 NIPBL BRWD1 NPAT | 4.67e-05 | 1492 | 100 | 17 | M40023 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 4.90e-05 | 441 | 100 | 9 | M172 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CCNL2 SRSF4 BUD13 EMSY NEK4 RNF220 MKI67 RBM15B RSRP1 NKTR RERE NPAT | 5.88e-05 | 807 | 100 | 12 | M14594 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 7.70e-05 | 363 | 100 | 8 | M41103 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 8.51e-05 | 474 | 100 | 9 | M40991 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 TANK SRSF3 AHCTF1 RABGAP1 NEK4 PIKFYVE PTPN13 BAZ1A PRRC2C NIPBL NPAT | 1.03e-04 | 856 | 100 | 12 | M4500 |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.14e-04 | 198 | 100 | 6 | M8036 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 1.17e-04 | 199 | 100 | 6 | M5429 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.20e-04 | 200 | 100 | 6 | M9472 | |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 1.20e-04 | 200 | 100 | 6 | M4768 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.20e-04 | 200 | 100 | 6 | M4449 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | KIF21B SRSF4 AKAP17A WHAMM GIT2 REXO1 DIP2A RSRP1 NKTR TRPT1 | 1.57e-04 | 634 | 100 | 10 | M40866 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | GTPBP4 AHCTF1 EPB41L4A NEK4 DDX46 RBM27 BAZ1A TJP1 PRRC2C ACIN1 SCAF11 PLEKHO1 NIPBL | 9.04e-07 | 532 | 97 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA2 LPCAT1 TANK RABGAP1 GIT2 ANKRD6 EMSY PIKFYVE BAZ1A MKI67 SCAF11 NKTR RERE NIPBL | 1.20e-05 | 780 | 97 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | KLF12 SRSF3 ZC3H13 PEG3 NCBP3 PRRC2C LUC7L2 ACIN1 SCAF11 NKTR | 1.94e-05 | 413 | 97 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NCOA2 GTPBP4 LPCAT1 GIT2 ANKRD6 EPB41L4A TUSC1 NEK4 DDX46 BAZ1A MKI67 NKTR RERE NIPBL | 2.43e-05 | 831 | 97 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NCOA2 MYCN KIF21B KLF12 ZC3H13 PEG3 NPHP4 TP53INP2 EMSY BAZ1A TLL1 MKI67 RBM15B RIMS1 RERE PLEKHO1 NIPBL BRWD1 | 4.28e-05 | 1370 | 97 | 18 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | DTD1 MYCN SRSF3 SRSF5 GTSE1 KATNB1 BUD13 ZFP36L1 GLYR1 TOP3A FAM110B | 8.32e-05 | 593 | 97 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 9.76e-05 | 404 | 97 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.01e-04 | 406 | 97 | 9 | gudmap_developingGonad_e16.5_epididymis_500 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-07 | 167 | 100 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-07 | 185 | 100 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.13e-07 | 186 | 100 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.04e-07 | 196 | 100 | 7 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.15e-07 | 197 | 100 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.26e-07 | 198 | 100 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.77e-06 | 192 | 100 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.92e-06 | 193 | 100 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 195 | 100 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 195 | 100 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 195 | 100 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.53e-06 | 197 | 100 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.86e-06 | 199 | 100 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.86e-06 | 199 | 100 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.03e-06 | 200 | 100 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.03e-06 | 200 | 100 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 153 | 100 | 5 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 153 | 100 | 5 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-05 | 161 | 100 | 5 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-05 | 164 | 100 | 5 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 172 | 100 | 5 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 180 | 100 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-05 | 181 | 100 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 182 | 100 | 5 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 185 | 100 | 5 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.59e-05 | 188 | 100 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.28e-05 | 192 | 100 | 5 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.28e-05 | 192 | 100 | 5 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.28e-05 | 192 | 100 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 192 | 100 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.28e-05 | 192 | 100 | 5 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 195 | 100 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 100 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 100 | 5 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-05 | 196 | 100 | 5 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-05 | 196 | 100 | 5 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 100 | 5 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 100 | 5 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors|bone_marrow / Manually curated celltypes from each tissue | 8.03e-05 | 196 | 100 | 5 | 4143dab6dce3c88c9b002c64699ab453149990e7 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 197 | 100 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 100 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-05 | 198 | 100 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.42e-05 | 198 | 100 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-05 | 198 | 100 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 100 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.42e-05 | 198 | 100 | 5 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.42e-05 | 198 | 100 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Mild/Remission-B_naive-9|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.62e-05 | 199 | 100 | 5 | e9af3c6a05f435ac8d7066f54feb653012b51ffb | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Mild/Remission-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.62e-05 | 199 | 100 | 5 | 0451b1536be3725a520bfdd2b3dff133bea812e8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 200 | 100 | 5 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 8.83e-05 | 200 | 100 | 5 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 200 | 100 | 5 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendendrocytes_NG2_cells_(Tnr-Cspg5)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 109 | 100 | 4 | 87f647cfebbb7de725e434cc27058e1c6accbb90 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 109 | 100 | 4 | e3696d84da1dcd15f15d0434ea9d1955f2af22d6 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendendrocytes_NG2_cells_(Tnr-Cspg5)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 109 | 100 | 4 | 6678036ff66c825a18d2506e33be421c27cf82e1 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 109 | 100 | 4 | c9d1e69f9841135f4d114563a293a69a8ba5f965 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 129 | 100 | 4 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 130 | 100 | 4 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 132 | 100 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| Computational | Neighborhood of DDX5 | 5.69e-05 | 63 | 71 | 5 | GNF2_DDX5 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.04e-06 | 191 | 100 | 8 | 4168_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 2.38e-06 | 195 | 100 | 8 | 6913_UP | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.47e-06 | 196 | 100 | 8 | 2239_DN | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 5835_UP | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 4744_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.67e-06 | 198 | 100 | 8 | 1002_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.10e-05 | 172 | 100 | 7 | 1072_DN | |
| Drug | AC1NRA5C | 1.19e-05 | 174 | 100 | 7 | CID005287709 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.19e-05 | 174 | 100 | 7 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.43e-05 | 179 | 100 | 7 | 5822_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 1.89e-05 | 187 | 100 | 7 | 448_DN | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 3345_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 4361_DN | |
| Drug | Homocysteine | 2.48e-05 | 195 | 100 | 7 | ctd:D006710 | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 5388_DN | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 2085_UP | |
| Drug | 5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.48e-05 | 195 | 100 | 7 | 889_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 1181_UP | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 5685_UP | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 7311_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 2070_DN | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.83e-05 | 199 | 100 | 7 | 6828_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 7030_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.17e-04 | 173 | 100 | 6 | 4458_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.20e-04 | 174 | 100 | 6 | 1659_DN | |
| Drug | trans-10,cis-12-conjugated linoleic acid | 1.28e-04 | 176 | 100 | 6 | ctd:C496197 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.40e-04 | 179 | 100 | 6 | 2105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.45e-04 | 180 | 100 | 6 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.54e-04 | 182 | 100 | 6 | 1891_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.54e-04 | 182 | 100 | 6 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.54e-04 | 182 | 100 | 6 | 1951_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.58e-04 | 183 | 100 | 6 | 7498_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.58e-04 | 183 | 100 | 6 | 7443_UP | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.63e-04 | 184 | 100 | 6 | 4349_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.63e-04 | 184 | 100 | 6 | 1007_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 185 | 100 | 6 | 2215_UP | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 185 | 100 | 6 | 3369_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.73e-04 | 186 | 100 | 6 | 1664_UP | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; PC3; HT_HG-U133A | 1.83e-04 | 188 | 100 | 6 | 6885_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.89e-04 | 189 | 100 | 6 | 3733_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 190 | 100 | 6 | 3833_DN | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 191 | 100 | 6 | 2861_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.00e-04 | 191 | 100 | 6 | 5210_DN | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 2.05e-04 | 192 | 100 | 6 | 6914_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 2.05e-04 | 192 | 100 | 6 | 1599_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.05e-04 | 192 | 100 | 6 | 993_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 100 | 6 | 5629_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.11e-04 | 193 | 100 | 6 | 965_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3854_UP | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 4371_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; HL60; HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1409_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 2900_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 4107_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3840_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 2637_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 6821_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 2808_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 1522_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 2.23e-04 | 195 | 100 | 6 | 1956_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 6803_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 3710_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 6583_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 4961_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 1290_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.23e-04 | 195 | 100 | 6 | 1132_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2310_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4148_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4296_DN | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 7044_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6775_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2270_UP | |
| Drug | rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.30e-04 | 196 | 100 | 6 | 921_DN | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4819_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 5489_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 5540_DN | |
| Drug | LY294002; Down 200; 10uM; PC3; HG-U133A | 2.30e-04 | 196 | 100 | 6 | 461_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 7276_UP | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3259_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; HL60; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2441_UP | |
| Drug | geldanamycin | 2.33e-04 | 371 | 100 | 8 | ctd:C001277 | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2644_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 5482_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3442_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 7199_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6094_DN | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2135_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 2.36e-04 | 197 | 100 | 6 | 1042_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 7463_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3299_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 4553_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 1501_UP | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 4816_UP | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; PC3; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 7278_UP | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 1538_DN | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 6302_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 5814_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 6450_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 5524_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A | 2.43e-04 | 198 | 100 | 6 | 664_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 6827_DN | |
| Disease | adult onset asthma | 5.62e-04 | 118 | 94 | 4 | EFO_1002011 | |
| Disease | sleep quality | 5.62e-04 | 118 | 94 | 4 | EFO_0005272 | |
| Disease | von Willebrand factor measurement, coagulation factor measurement | 6.49e-04 | 12 | 94 | 2 | EFO_0004629, EFO_0004634 | |
| Disease | mean reticulocyte volume | 1.02e-03 | 799 | 94 | 9 | EFO_0010701 | |
| Disease | mean arterial pressure | 1.09e-03 | 499 | 94 | 7 | EFO_0006340 | |
| Disease | respiratory system disease | 1.21e-03 | 145 | 94 | 4 | EFO_0000684 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 1.24e-03 | 66 | 94 | 3 | EFO_0007708 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.44e-03 | 152 | 94 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Manic Disorder | 1.53e-03 | 71 | 94 | 3 | C0024713 | |
| Disease | juvenile idiopathic arthritis | 1.72e-03 | 74 | 94 | 3 | EFO_0002609 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.84e-03 | 20 | 94 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Manic | 2.00e-03 | 78 | 94 | 3 | C0338831 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.03e-03 | 21 | 94 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Depression, Bipolar | 2.08e-03 | 79 | 94 | 3 | C0005587 | |
| Disease | progranulin measurement | 2.23e-03 | 22 | 94 | 2 | EFO_0004625 | |
| Disease | congenital heart disease (is_implicated_in) | 2.65e-03 | 24 | 94 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | platelet component distribution width | 2.85e-03 | 755 | 94 | 8 | EFO_0007984 | |
| Disease | colon adenocarcinoma (is_marker_for) | 2.87e-03 | 25 | 94 | 2 | DOID:234 (is_marker_for) | |
| Disease | Crohn's disease | 2.90e-03 | 441 | 94 | 6 | EFO_0000384 | |
| Disease | age at menarche | 2.93e-03 | 594 | 94 | 7 | EFO_0004703 | |
| Disease | Cholangiocarcinoma | 3.10e-03 | 26 | 94 | 2 | C0206698 | |
| Disease | inflammatory bowel disease | 3.17e-03 | 449 | 94 | 6 | EFO_0003767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSRRERSKDASPINR | 421 | Q13523 | |
| SDDEKPRKGERRSSR | 216 | Q9UKV3 | |
| DRDKVREGPRSRSRS | 1166 | Q9UKV3 | |
| RRSSSQELSENDKPR | 616 | Q5RHP9 | |
| SPPRRRQRTKSSDSD | 391 | Q9BRD0 | |
| GPQRERKSSSSSEDR | 421 | P15056 | |
| RCSSRPSRDSDRLQL | 141 | Q400G9 | |
| EREKRTSQSARRPTC | 451 | Q76N32 | |
| SRSITRKRKREDSAP | 546 | Q9BZE4 | |
| RGRAKPSRDSSREER | 1016 | Q99490 | |
| RRASRLEKQNSTPES | 576 | Q14161 | |
| ETLDSKARSDAAPRR | 121 | Q5VUD6 | |
| SRRLSSRQRPSLESD | 1201 | Q9NRL2 | |
| DRRRKSRPKVSAFSD | 336 | Q9Y2G4 | |
| SSSSAKRPREREREA | 16 | Q8NDT2 | |
| PQKTRSESSERRTRE | 121 | Q9P2N5 | |
| SRSRGRSKDRDPNRN | 181 | Q9P2N5 | |
| RTPGSSARSQKREAR | 186 | Q9BTK6 | |
| DERERNSRPSSKNLT | 1376 | Q14207 | |
| SERERRKTTASPSVR | 481 | Q9Y3P9 | |
| SEDARSSPSQRRRGE | 26 | P33991 | |
| SAASARRKPRAEDQT | 161 | Q9BU76 | |
| RPVFVSRSDQDSRRK | 171 | Q8NF37 | |
| SSKERRTSSKERRAP | 731 | Q9UJ55 | |
| STANRQNRPKSRESR | 1211 | Q12791 | |
| DSQRSQTEPARERKR | 56 | O95872 | |
| SSPTRREAVKRRTAE | 281 | Q96S38 | |
| SRAAEAAATTPRRAR | 61 | Q0VG99 | |
| SERRSPSSEDDRDER | 356 | Q9BVA0 | |
| SDSSPSRRQRLEEAK | 1006 | Q9UPA5 | |
| SSSKDRPLSARERRR | 606 | P51957 | |
| ASTARRRSREEAEKP | 61 | Q6ZU69 | |
| STRDPDTRHRRSNIK | 161 | O75037 | |
| DDKNRRNSSEERSRP | 106 | Q49A26 | |
| DQSRVRRPETLRSSS | 836 | Q6KC79 | |
| KQPRERSASRRSSAS | 381 | Q53F19 | |
| LEDTATSSKRRPRTR | 2831 | P46013 | |
| RDASPSKEERKRSRT | 11 | Q9BUQ8 | |
| RTEPTRESNRKTDSR | 556 | Q9NYZ3 | |
| ARESSDRSQRFPRMS | 331 | Q9GZU2 | |
| PQDVSRESDATRRRK | 901 | O75161 | |
| SARTRARRPESKATN | 21 | P25116 | |
| SPENDRHSRKSERSS | 1156 | Q86UR5 | |
| SRDDFFRTKPRSASR | 411 | A8MVW0 | |
| ASDRKRSPSVSRDQN | 261 | Q9UQ26 | |
| RRTSRCSDEERPSTS | 786 | Q6PIJ6 | |
| QRRSSALDTRRKAEP | 101 | Q9Y2I7 | |
| SSKERNTPRKEDRSA | 181 | Q8TEA8 | |
| RRLIESRSASPDSRK | 296 | Q9H4Z3 | |
| LDSDSDERPTRSRRL | 1071 | Q8TD26 | |
| SSRSRSRSRERADNP | 466 | Q96S94 | |
| SVRRRQKPSDRADSR | 596 | Q9BY84 | |
| PRTFKRRADDTSGDR | 206 | Q8IXQ4 | |
| SDQDSDSDQPSRKRR | 1081 | Q6PD62 | |
| SRKRRPSGSEQSDNE | 1091 | Q6PD62 | |
| SDRSRERKVPASRIS | 76 | Q96D53 | |
| SDSAESSERRKRNRP | 1506 | Q9NSI6 | |
| SRRPSLQRSKSDLSD | 251 | Q8TC76 | |
| SIESTRRQRRSESPD | 296 | Q9Y4X4 | |
| DEDEKPRKRRRTNSS | 196 | Q7Z589 | |
| RRRSTRNTPAKSENV | 2006 | Q8WYP5 | |
| KSRPTASRDERFRSD | 81 | Q14689 | |
| SPSDKRSKRGDDRRS | 26 | Q7L014 | |
| RHRSRSRSPDIQAKE | 536 | Q9HCS5 | |
| ARERRQSQSRSPKRD | 856 | Q99590 | |
| SPKRDTTRESRRSES | 866 | Q99590 | |
| LSPRRETSRENKRSQ | 881 | Q99590 | |
| KSRSQSRERESDRDG | 906 | Q99590 | |
| RNDSSRSEASRPSTR | 186 | Q3SYA9 | |
| NRSPERRKHESDSSS | 1031 | Q12923 | |
| RTSESSLARPRQSRE | 971 | A6NGG8 | |
| ASCDRDRSSRDRSPR | 346 | Q9Y383 | |
| DRSSRDRSPRDRDRK | 351 | Q9Y383 | |
| ASSDSKRRAQAPRDR | 806 | A6ND36 | |
| REDPNSRSRFRSKKE | 276 | Q5JY77 | |
| SRASSRDERAAKRPR | 246 | Q8N1G1 | |
| KEDTDRSQSRSPSRS | 396 | Q08170 | |
| NRDITSRKDLPSRTS | 66 | Q9BYT3 | |
| EKNRVPRAATSRTER | 141 | O43897 | |
| DDDSQSRSPSRSRSK | 1306 | P30414 | |
| KRRRQRGSETDTDSE | 1256 | Q9Y520 | |
| NVDVRPKTSRSRSAD | 11 | Q8WXH5 | |
| RRQEVSSPRKETSAR | 111 | Q92844 | |
| SKPTSNRRTSDLERS | 766 | Q8TF30 | |
| RDKARESENSRPRRS | 26 | Q9P2R6 | |
| REASSSPEDRNDRCK | 196 | Q5VTB9 | |
| SRRRADSDRIQPSAD | 221 | Q53GL0 | |
| ECQSSPKHSSRERRR | 236 | Q86TN4 | |
| SRSKSPASVDRQRSR | 246 | Q13243 | |
| RSRSRTPFRLSEKDR | 161 | Q9BUV0 | |
| KPRDSQAETRADRSK | 586 | Q9UPX8 | |
| ARRASSREDGRPRKE | 606 | Q02040 | |
| ENTSDPSRAETRKRK | 6 | Q15596 | |
| APALSSRDSRFRDRS | 76 | Q07352 | |
| CSRSSRSKPRDQREE | 226 | A6PVC2 | |
| SPRNSDSEDSERRRN | 371 | P04198 | |
| RESRPRRSKNQSSFI | 196 | Q8IXH6 | |
| SRSRSPNKARDCSRS | 426 | B3KS81 | |
| ARDRSRSRSPNKARD | 446 | B3KS81 | |
| SKERDHRRSRSPSKE | 516 | B3KS81 | |
| SRSPNKERDRSQSRS | 536 | B3KS81 | |
| KERDRSQSRSPSEER | 541 | B3KS81 | |
| ERSLSRERNHKPSRS | 136 | P84103 | |
| RNLSSEEVARPRRST | 166 | Q9BQI5 | |
| DSEESRPRARAKQVR | 866 | Q96HA7 | |
| ADRKIRLSSSASREP | 111 | Q96MU7 | |
| SSKDTRKRPRDDSDS | 341 | Q92797 | |
| RTLESEARSKRPRAS | 956 | Q13472 | |
| ASRERSLSPRSDRRS | 161 | Q07157 | |
| RERTAKKSRRDNETP | 276 | O75541 | |
| RRDSSRAASRPRKAE | 16 | Q63HR2 | |
| SRDTKESRDPRDSRS | 486 | Q5T200 | |
| ESRDPRDSRSTRDAH | 491 | Q5T200 | |
| RVPEEASTNRRARDS | 131 | Q2TAM9 | |
| SDSNCDDRKRPTLRR | 1576 | P82987 |